However, ephrinB2-EphB4-mediated (onco)biological effects are extremely variable depending on tumor biology, microenvironment, presence or absence of ligand-dependent and ligand-independent signaling, in addition to forward and backward signaling mechanisms. Here, EPHB4 is linked to neoplasm.